Ajay Samkaria/LinkedIn
Jun 9, 2026, 17:53
Ajay Samkaria: How ABO Subgroups Directly Impact Transfusion Safety
Ajay Samkaria, Product and Application Manager at DIAGAST, shared a post on LinkedIn:
“ABO subgroups are more than just laboratory curiosities—they are clinically significant and can directly impact transfusion safety.
Weak or variant antigen expressions may lead to blood grouping discrepancies, incompatible transfusions, and delayed clinical decisions if not properly identified.
Highlights:
- Classification of A, B and O subgroups.
- Bombay (Oh) and Para Bombay phenotypes.
- Rare phenotypes such as INA and INB.
- Clinical and immunohematological significance.
- Common methods for subgroup confirmation.
Accurate detection and confirmation of ABO subgroups remain essential for safe transfusion practice and quality immunohematology reporting.”
Stay updated with Hemostasis Today.
-
Jun 9, 2026, 17:55Can We Prevent Postpartum Blood Clots without Putting Most Women on Heparin? – RPTH Journal
-
Jun 9, 2026, 17:54Lucky Oseghale Oloboh: Health Is Power, Health Is Personal, and Health Is Our First Responsibility in Life’s Journey on Mother Earth
-
Jun 9, 2026, 17:51Alejandro González Veliz: Most Reported Aspirin Allergies Are Not True Hypersensitivity
-
Jun 9, 2026, 17:50Mary Cushman: It’s Time to Apply to Be on an ISTH SSC
-
Jun 9, 2026, 15:56Wolfgang Miesbach: A New Genetic Perspective on the Worldwide Burden of von Willebrand Disease
-
Jun 9, 2026, 15:34Shanon Marie Corsino: Nationwide Insights into Cancer-Associated Thrombosis in Filipino Patients
-
Jun 9, 2026, 15:20Murtuza Ali: Types of Blood Transfusions – A Quick Clinical Guide
-
Jun 9, 2026, 15:18Mital Jhaveri: TRACK Trial Findings Highlight the Unique Challenges of Advanced CKD
-
Jun 9, 2026, 14:56Mohamed Adel: Nursing Management of Patients with Thrombocytopenia